The Weekly Scale: April 12th, 2021

 

This week at MarketScale, we explored how 5G is being brought to life, the infrastructure that will power it, and why the edge might be the answer.

We also sat down with a global fashion leader, picked an Adobe exec’s brain about the future of education, and more.

It’s the start of a new week, and it’s time to scale up.

5G dominates the news, but do you know the three technologies that intersect to create an innovative and flexible solution expanding the reach and use cases of 5G technology?

This week on The Rugged Edge Survival Guide, Peter Hsu, a Solutions Architect with Premio, provided his take on how the challenge of edge computing right now is not to be the bottleneck within this whole 5G infrastructure.

It’s not every day that you get to pick the brain of the creative leader of a global fashion brand. But today could be your lucky day.

Sandra Choi, Creative Director of J. Choo Limited joined the podcast “Then What” to dive into how she finds sources of inspiration and how she develops personal qualities like creativity, responsibility and kindness.

Would this massive shift to remote working and learning have worked without Adobe digital tools like PDFs and Portfolio?

Adobe VP & GM of the Creative Cloud Product line, Mala Sharma, joined EdTech Today with Kevin Hogan to dive into how the tech giant has jump-started an important, longer-term conversation about what is and isn’t working in our current education system.

Is the U.S. education system behind in mass adopting technology?

Global Education General Manager with the Intel Internet of Things (IoT) Group, We Oania, joined the Voices of eLearning podcast to shine a light on the problems teachers faced before the pandemic and how the company is working with teachers to eliminate repetitive tasks so they can focus on what they want to teach and engaging students.

Is the management side of the hospitality industry ready to take on this massive influx in travelers? On this week’s MarketScale Roundtable, we’ll explore which hospitality management structures or roles changed the most due to COVID

The panel will include:
Glenn Haussman- No Vacancy podcast
Orietta Verdugo – Intel
Brad Beakley – Hospitio

Make sure to follow along for future roundtables. We will also be checking out the future of Careers in Manufacturing & Automation on April 19th.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

 

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More